Taking a Look at the Data Behind Lam Research Corporation (LRCX)

Yolanda Curtis
October 19, 2017

The company's Market capitalization is $7.37B with the total Outstanding Shares of 658.50M. The rating was initiated by Barclays Capital on Wednesday, September 6 with "Hold". Taking a wider view, the current separation from the 52-week high is -4.51%, and the distance from the 52-week low is presently 9.44%. The stock of Sarepta Therapeutics Inc (NASDAQ:SRPT) earned "Outperform" rating by Wedbush on Wednesday, July 20. RBC Capital Markets maintained it with "Buy" rating and $185.0 target in Wednesday, August 30 report.

Among 21 analysts covering Lam Research Corporation (NASDAQ:LRCX), 18 have Buy rating, 0 Sell and 3 Hold.

The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. More interesting news about Lam Research Corporation (NASDAQ:LRCX) were released by: Seekingalpha.com and their article: "Lam Research Can Run Higher" published on September 26, 2017 as well as Globenewswire.com's news article titled: "Lam Research Corporation Reports Financial Results for the Quarter Ended ..." with publication date: October 17, 2017. Analysts giving shares a rating of 1 or 2 would be indicating a Buy.


Lam Research Corporation shares were trading at $194.55 per share on Tuesday afternoon, up $2.19 (+1.14%). The firm has "Hold" rating by KeyBanc Capital Markets given on Friday, September 22. The firm earned "Buy" rating on Thursday, October 6 by DA Davidson. Argus began coverage on Lam Research Corporation in a research report on Tuesday, September 12th. Stifel Nicolaus maintained the shares of LRCX in report on Thursday, October 20 with "Buy" rating. The rating was maintained by Needham on Friday, July 22 with "Buy". Cowen & Co maintained the shares of LRCX in report on Thursday, December 10 with "Outperform" rating. The short-interest ratio decreased to 5.0 and the percentage of shorted shares is 0.07% as of September 29.

ATR remains at 0.14 while Beta component of the stock stands at 1.24. The value of the company's investment in Lam Research Corporation increased from $197,407,000 to $215,855,000 a change of 9.3% quarter over quarter. Wetherby Asset Management reported 0.04% stake. Hanseatic Mngmt Svcs, a New Mexico-based fund reported 2,242 shares. E&G Advsrs Ltd Partnership accumulated 3,100 shares or 0.21% of the stock. Murphy Mgmt Incorporated holds 0.15% or 7,250 shares in its portfolio. Pnc Fincl Grp holds 0.12% of its portfolio in Lam Research Corporation (NASDAQ:LRCX) for 821,588 shares. The stock declined 0.38% or $0.05 reaching $13.28 per share. It is negative, as 43 investors sold Lam Research Corporation shares while 255 reduced holdings. Janus Capital Management LLC now owns 3,608,710 shares of the semiconductor company's stock valued at $463,214,000 after acquiring an additional 433,555 shares in the last quarter. Cadence Mngmt Ltd Liability Com holds 113,040 shares. 79,939 are owned by Kbc Gru Nv.

Newberry sold 750 shares of Lam Research Corporation stock. Crosslink Capital has 2.81% invested in Lam Research Corporation (NASDAQ:LRCX). Smith Asset Mgmt Lp accumulated 808 shares. About 1.59M shares traded.


Kbc Group Nv increased Lam Research Corp (LRCX) stake by 106.74% reported in 2017Q2 SEC filing. It has outperformed by 52.99% the S&P500.

Since May 18, 2017, it had 0 insider buys, and 3 selling transactions for $4.83 million activity. 8,942 shares valued at $1.39 million were sold by ARCHER TIMOTHY on Monday, June 12. 2,770 shares were sold by LORD PATRICK J, worth $430,320. $3.01M worth of Lam Research Corporation (NASDAQ:LRCX) was sold by NEWBERRY STEPHEN G on Thursday, May 18. The company has market cap of $391.20 million. The Company designs, manufactures, markets, refurbishes and services semiconductor processing systems that are used in the fabrication of integrated circuits (ICs). It has a 28 P/E ratio. WIS operates under the brand, WesternOne Infrastructure Services and provides heat and related services to the construction, infrastructure and gas and oil sectors, and aerial equipment for construction, television and movie production.

Investors sentiment decreased to 1.22 in 2017 Q2. LRCX exchanged 2.84 million shares in recent session versus to the average volume of 2.15 million shares while its relative volume is 1.33. 105 funds opened positions while 667 raised stakes. First Houston Cap reported 0.24% stake. First Foundation, California-based fund reported 7,995 shares. Thompson Davis holds 0.01% or 38 shares in its portfolio. Vanguard holds 0.11% or 16.16 million shares. Interocean Capital Limited Liability Com holds 156,453 shares. Credit Suisse Ag has invested 0% in Sarepta Therapeutics Inc (NASDAQ:SRPT). Mitsubishi Ufj Holdg holds 0.83% or 1,100 shares. Swiss Commercial Bank reported 0% of its portfolio in Sarepta Therapeutics Inc (NASDAQ:SRPT). Conning owns 3,933 shares for 0.02% of their portfolio. It dropped, as 50 investors sold JNJ shares while 878 reduced holdings. Pinnacle Associate Limited holds 0.22% or 341,816 shares.


Other reports by iNewsToday

FOLLOW OUR NEWSPAPER